Antiretroviral Medications and Their Impact on Brain Health
Author Information
Author(s): Brian Giunta, Jared Ehrhart, Demian F. Obregon, Lucy Lam, Lisa Le, JingJi Jin, Francisco Fernandez, Jun Tan, R. Douglas Shytle
Primary Institution: University of South Florida
Hypothesis
Do antiretroviral medications affect the production and clearance of amyloid beta in the brain?
Conclusion
Antiretroviral medications increase the production of amyloid beta and inhibit its clearance by microglial cells, potentially contributing to cognitive decline in HIV-infected individuals.
Supporting Evidence
- ART medications generally increase Aβ generation in cultured neuronal cells.
- ART medications inhibit microglial phagocytosis of Aβ1-42 peptides.
- The most significant effects were observed with combined ART treatments.
Takeaway
Some medicines used to treat HIV can make a substance in the brain called amyloid beta build up more and get cleaned up less, which might make it harder for people to think clearly.
Methodology
The study evaluated the effects of various antiretroviral medications on amyloid beta production in murine cells and microglial phagocytosis.
Potential Biases
Potential bias due to the focus on specific antiretroviral medications and their effects without considering broader treatment contexts.
Limitations
The study was limited to in vitro experiments and did not account for other brain cell types or factors.
Participant Demographics
Murine models were used, with no human participant demographics provided.
Statistical Information
P-Value
p < 0.05
Statistical Significance
p < 0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website